David Chung is the founder of NeoChord. NeoChord has raised $32M in total funding. Latest round: Series D. Based in St Louis Park, USA.
David Chung is the President and CEO of NeoChord. NeoChord is a company focused on developing catheter-based technologies for patients with mitral regurgitation, leveraging its commercial experience in Europe with beating heart chordal replacement. The company recently secured additional funding as an extension of its Series D equity financing, bringing its total raised in the past 12 months to over $32 million.
Full founder directory · Investor directory · Company funding database · Fundraising library